Search results
Gateway - The Root
The Root· 2 days agoPer a press release provided to The Root, “Mom-in-Chief” Michelle Obama is starring in a new PSA alongside (in...
Household study suggests infants may spread C difficile
Center for Infectious Disease Research and Policy· 6 days agoA longitudinal household study found shared C difficile strains in 17 of 28 families, with the...
Gateway - The Root
The Root· 2 days agoIf you thought something as insignificant as a COVID-19 mandate in New York City that requires people to provide proof of vaccination in order to enter arenas, gyms, restaurants, and other indoor ...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 7 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
COVID-19 pandemic’s $15 billion price tag in Nevada: State’s report analyzes human toll
KLAS articles via Yahoo News· 2 days agoCOVID-19 was the third-leading cause of death in Nevada from 2020 to 2022, behind only heart disease...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
New Study: How Vaccination Impacts Long COVID Recovery
SciTechDaily· 2 days agoResearch by Columbia University on over 4,700 participants shows that long COVID has a varied...
Gateway - The Root
The Root· 2 days agoHealth expert, Dr. Melissa Clarke, dropped some reasons to The Root about Covid and why it’s still around. Variants can have an advantage over the parent virus, which allows them to infect people more easily or become more deadly.
Gateway - Jalopnik
Jalopnik· 2 days agoOver four thousand flights in the United States have been canceled today and across the Christmas weekend. The number of canceled flights soars over ten thousand when flights in other countries ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 3 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
